Bhatia SN, Chen X, Dobrovolskaia MA, Lammers T. Cancer nanomedicine. Nat Rev Cancer. 2022;22:550–6.

CAS  PubMed  PubMed Central  Google Scholar 

Lammers T, Kiessling F, Hennink WE, Storm G. Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol Pharmaceutics. 2010;7:1899–912.

CAS  Google Scholar 

Chen H, Zhang W, Zhu G, Xie J, Chen X. Rethinking cancer nanotheranostics. Nat Rev Mater. 2017;2:17024.

CAS  PubMed  PubMed Central  Google Scholar 

Van Der Meel R, Sulheim E, Shi Y, Kiessling F, Mulder WJM, Lammers T. Smart cancer nanomedicine. Nat Nanotechnol. 2019;14:1007–17.

PubMed  PubMed Central  Google Scholar 

Jin CS, Wada H, Anayama T, McVeigh PZ, Hu HP, Hirohashi K, et al. An integrated nanotechnology-enabled transbronchial image-guided intervention strategy for peripheral lung cancer. Cancer Res. 2016;76:5870–80.

CAS  PubMed  PubMed Central  Google Scholar 

Kinoshita T, Ujiie H, Chen J, Ding L, Chan H, Gregor A, et al. Evaluation of novel imaging devices for nanoparticle-mediated fluorescence-guided lung tumor therapy. Ann Thorac Surg. 2019;107:1613–20.

PubMed  Google Scholar 

Jin CS, Overchuk M, Cui L, Wilson BC, Bristow RG, Chen J, et al. Nanoparticle-enabled selective destruction of prostate tumor using MRI-guided focal photothermal therapy: porphysome enabled MRI-guided focal photothermal therapy. Prostate. 2016;76:1169–81.

CAS  PubMed  Google Scholar 

Muhanna N, Jin CS, Huynh E, Chan H, Qiu Y, Jiang W, et al. Phototheranostic porphyrin nanoparticles enable visualization and targeted treatment of head and neck cancer in clinically relevant models. Theranostics. 2015;5:1428–43.

CAS  PubMed  PubMed Central  Google Scholar 

Sahovaler A, Valic MS, Townson JL, Chan HHL, Zheng M, Tzelnick S, et al. Nanoparticle-mediated photodynamic therapy as a method to ablate oral cavity squamous cell carcinoma in preclinical models. Cancer Res Commun. 2024;4:796–810.

CAS  PubMed  PubMed Central  Google Scholar 

Guidolin K, Ding L, Chen J, Zheng G. Development of a clinically viable strategy for nanoparticle-based photodynamic therapy of colorectal cancer. Adv Ther. 2023;6:2200342.

Google Scholar 

Lovell JF, Jin CS, Huynh E, Jin H, Kim C, Rubinstein JL, et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater. 2011;10:324–32.

CAS  PubMed  Google Scholar 

MacDonald TD, Liu TW, Zheng G. An MRI-sensitive, non-photobleachable porphysome photothermal agent. Angew Chem Int Ed. 2014;53:6956–9.

CAS  Google Scholar 

Liu TW, MacDonald TD, Shi J, Wilson BC, Zheng G. Intrinsically copper-64-labeled organic nanoparticles as radiotracers. Angew Chem Int Ed. 2012;51:13128–31.

CAS  Google Scholar 

Liu TW, MacDonald TD, Jin CS, Gold JM, Bristow RG, Wilson BC, et al. Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases. ACS Nano. 2013;7:4221–32.

CAS  PubMed  PubMed Central  Google Scholar 

Philp L, Chan H, Rouzbahman M, Overchuk M, Chen J, Zheng G, et al. Use of Porphysomes to detect primary tumour, lymph node metastases, intra-abdominal metastases and as a tool for image-guided lymphadenectomy: proof of concept in endometrial cancer. Theranostics. 2019;9:2727–38.

CAS  PubMed  PubMed Central  Google Scholar 

ICH M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals. U.S. Food and Drug Administration; 2010. p. 30. Report No.: Revision 1.

Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clin Pharmacokinet. 2003;42:419–36.

CAS  PubMed  Google Scholar 

Kirschner AS, Ice RD, Beierwaltes WH. Radiation dosimetry of 131I–19-iodocholesterol: the pitfalls of using tissue concentration data—reply. J Nucl Med. 1975;16:248.

CAS  Google Scholar 

Gaddy DF, Lee H, Zheng J, Jaffray DA, Wickham TJ, Hendriks BS. Whole-body organ-level and kidney micro-dosimetric evaluations of 64Cu-loaded HER2/ErbB2-targeted liposomal doxorubicin (64Cu-MM-302) in rodents and primates. EJNMMI Res. 2015;5:24.

PubMed  PubMed Central  Google Scholar 

Cicone F, Viertl D, Denoël T, Stabin MG, Prior JO, Gnesin S. Comparison of absorbed dose extrapolation methods for mouse-to-human translation of radiolabelled macromolecules. EJNMMI Res. 2022;12:21.

CAS  PubMed  PubMed Central  Google Scholar 

Valentin J, editor. Basic anatomical and physiological data for use in radiological protection: reference values. Oxford: Pergamon Press; 2003.

Google Scholar 

Stabin M, Emmons MA, Segars WP, Fernald M, Brill AB. ICRP-89 based adult and pediatric phantom series. J Nucl Med. 2008;49:14P.

Google Scholar 

The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP. 2007;37:1–332.

Cristy M, Eckerman KF. Specific absorbed fractions of energy at various ages from internal photon sources: 7, Adult male [Internet]. 1987 Apr [cited 2024 Sep 18] p. ORNL/TM-8381/V7, 6233638. Report No.: ORNL/TM-8381/V7, 6233638. Available from: http://www.osti.gov/servlets/purl/6233638/

Cristy M, Eckerman KF. Specific absorbed fractions of energy at various ages from internal photon sources: 5, Fifteen-year-old male and adult female [Internet]. 1987 Apr [cited 2024 Sep 18] p. ORNL/TM-8381/V5, 6263426. Report No.: ORNL/TM-8381/V5, 6263426. Available from: http://www.osti.gov/servlets/purl/6263426/

Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023–7.

PubMed  Google Scholar 

Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 [Internet]. US Department of Health and Human Services; 2017 [cited 2022 Jul 18]. Available from: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf

Allen TM, Hansen CB, de Menezes DEL. Pharmacokinetics of long-circulating liposomes. Adv Drug Deliv Rev. 1995;16:267–84.

CAS  Google Scholar 

Allen TM, Hansen C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1991;1068:133–41.

CAS  PubMed  Google Scholar 

Ouyang B, Poon W, Zhang Y-N, Lin ZP, Kingston BR, Tavares AJ, et al. The dose threshold for nanoparticle tumour delivery. Nat Mater. 2020;19:1362–71.

CAS  PubMed  Google Scholar 

Dams ETM, Laverman P, Oyen WJG, Storm G, Scherphof GL, Van Der Meer JWM, et al. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther. 2000;292:1071–9.

CAS  PubMed  Google Scholar 

Suzuki T, Ichihara M, Hyodo K, Yamamoto E, Ishida T, Kiwada H, et al. Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs. Int J Pharm. 2012;436:636–43.

CAS  PubMed  Google Scholar 

Li C, Cao J, Wang Y, Zhao X, Deng C, Wei N, et al. Accelerated blood clearance of pegylated liposomal topotecan: influence of polyethylene glycol grafting density and animal species. J Pharm Sci. 2012;101:3864–76.

CAS  PubMed  Google Scholar 

Armstrong JK, Hempel G, Koling S, Chan LS, Fisher T, Meiselman HJ, et al. Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients. Cancer. 2007;110:103–11.

PubMed  Google Scholar 

Sundy JS, Ganson NJ, Kelly SJ, Scarlett EL, Rehrig CD, Huang W, et al. Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout. Arthritis Rheum. 2007;56:1021–8.

CAS  PubMed  Google Scholar 

Shiraishi K, Kawano K, Maitani Y, Aoshi T, Ishii KJ, Sanada Y, et al. Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance. J Control Release. 2016;234:59–67.

CAS  PubMed  Google Scholar 

Caron WP, Clewell H, Dedrick R, Ramanathan RK, Davis WL, Yu N, et al. Allometric scaling of pegylated liposomal anticancer drugs. J Pharmacokinet Pharmacodyn. 2011;38:653–69.

CAS  PubMed  Google Scholar 

Caron WP, Morgan KP, Zamboni BA, Zamboni WC. A review of study designs and outcomes of phase I clinical studies of nanoparticle agents compared with small-molecule anticancer agents. Clin Cancer Res. 2013;19:3309–15.

CAS  PubMed  Google Scholar 

Kumar M, Kulkarni P, Liu S, Chemuturi N, Shah DK. Nanoparticle biodistribution coefficients: a quantitative approach for understanding the tissue distribution of nanoparticles. Adv Drug Deliv Rev. 2023;194:114708.

CAS  PubMed  Google Scholar 

Sohlenius-Sternbeck A-K. Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements. Toxicol In Vitro. 2006;20:1582–6.

CAS  PubMed  Google Scholar 

Lovell JF, Jin CS, Huynh E, MacDonald TD, Cao W, Zheng G. Enzymatic regioselection for the synthesis and biodegradation of porphysome nanovesicles. Angew Chem Int Ed. 2012;51:2429–33.

CAS  Google Scholar 

Stabin MG. OLINDA/EXM 2—The next-generation personal computer software for internal dose assessment in nuclear medicine. Health Phys. 2023;124:397–406.

CAS  PubMed  Google Scholar